Adare Pharma Solutions, a technology-driven CDMO, has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The acquisition expands Adare’s portfolio of offerings to include new capabilities such as high potency compound handling and packaging services.  The combination of the two organizations will further establish Adare as a leading development and manufacturing organization for complex dosage forms.   Together, the combined company will offer an expanded su...